Cite
HARVARD Citation
Tsai, P. et al. (2017). A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan. Kaohsiung journal of medical sciences. 33 (1), pp. 44-49. [Online].